News FDA to encourage approval of nicotine replacement therapies FDA commissioner wants to create new pathway
News European pharma calls for urgent Brexit medicines deal - but... ABPI and others concerned over potential disruption to supplies
News Catalyst to re-submit rare disease drug after trial success Already approved in EU, Catalyst aiming for FDA filing next year.
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
Partner Content Partner Content The 10th Annual Social Media in Pharma – Exclusive Speaker I... Social Media in Pharma
News EMA's post-Brexit location to be decided today The location of the European Medicines Agency after Brexit is to be decided today, as representatives of member states vote in a complex secret ballot that could end with a coin toss.
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
